Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial.

Raygan F, Behnejad M, Ostadmohammadi V, Bahmani F, Mansournia MA, Karamali F, Asemi Z

Open source

DOI
10.1017/s0007114518001253
Published
2018 Jul
Container
The British journal of nutrition
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/s0007114518001253,
  title = {Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial.},
  author = {Raygan F and Behnejad M and Ostadmohammadi V and Bahmani F and Mansournia MA and Karamali F and Asemi Z},
  year = {2018},
  journal = {The British journal of nutrition},
  doi = {10.1017/s0007114518001253},
  url = {https://doi.org/10.1017/s0007114518001253}
}

RIS

TY  - JOUR
TI  - Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial.
AU  - Raygan F
AU  - Behnejad M
AU  - Ostadmohammadi V
AU  - Bahmani F
AU  - Mansournia MA
AU  - Karamali F
AU  - Asemi Z
PY  - 2018
JO  - The British journal of nutrition
DO  - 10.1017/s0007114518001253
UR  - https://doi.org/10.1017/s0007114518001253
ER  - 

APA

F, R., M, B., V, O., F, B., MA, M., F, K., & Z, A. (2018). Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial.. The British journal of nutrition. https://doi.org/10.1017/s0007114518001253

Source records